KN
Neutral signalScored 2026-09-06 Drivers: fundamentals. Insiders: neutral. Moteurs : fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Knowles Corporation
- Nom
- Knowles Corporation
- Secteur
- Technology
- Industrie
- Hardware, Equipment & Parts
- Bourse
- NYSE
- Capitalisation
- $2.7B
- Employés
- 5,200
- PDG
- Jeffrey S. Niew
- Site web
- https://www.knowles.com
- Marché
- AAOIASGNBELFBNTCTONDSPAYO
Knowles Corporation is a leading provider of specialized electronic components, offering an array of micro-acoustic microphones, sophisticated balanced armature speakers, comprehensive audio solutions, high-performance capacitors, and advanced radio frequency products. These precision technologies serve diverse industries, including consumer electronics, medical technology (medtech), defense, electric vehicles, industrial applications, and communications. The company operates through two distinct segments. Its Audio segment is dedicated to engineering and manufacturing innovative audio components, such as microphones, balanced armature speakers, and audio processors. These are integral to applications across mobile devices, hearing health solutions, True Wireless Stereo (TWS) products, the Internet of Things (IoT), and computing platforms. Concurrently, the Precision Devices (PD) segment focuses on the development and delivery of high-specification capacitor products and RF solutions. These critical components find use in demanding applications like power supplies, medical implants, satellite communications, radar systems, and general communications equipment. Knowles distributes its offerings directly to original equipment manufacturers (OEMs), their contract manufacturers, and suppliers, as well as through an established network of distributors. With a global footprint spanning Asia, the United States, Europe, and other parts of the Americas, the company, established in 1946, maintains its headquarters in Itasca, Illinois.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 206 618 titres (~8 050 092,67 $ US)
- Insiders
- SHAVERS CHERYL LNiew Jeffrey
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$9,357,578
Avg sell (VWAP, 90d window) $38.96 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$9,357,578 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-08-17
- Last synced
-
2026-08-23 00:12:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-17 | SHAVERS CHERYL L | Sell · S · 10b5-1 | 175 | $39.28 | $6,874 | Form 4 |
| 2026-08-14 | Niew Jeffrey | Sell · S · 10b5-1 | 6,951 | $38.00 | $264,138 | Form 4 |
| 2026-08-13 | Niew Jeffrey | Sell · S · 10b5-1 | 43,049 | $38.69 | $1,665,566 | Form 4 |
| 2026-08-13 | Anderson John S. | Sell · S · 10b5-1 | 10,000 | $38.84 | $388,400 | Form 4 |
| 2026-08-12 | Niew Jeffrey | Sell · S · 10b5-1 | 150,000 | $39.07 | $5,860,500 | Form 4 |
| 2026-08-12 | Anderson John S. | Sell · S · 10b5-1 | 30,000 | $39.07 | $1,172,100 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-09-06 Drivers: fundamentals. Insiders: neutral. Moteurs : fondamentaux. Initiés : neutre.
KN presents solid liquidity (85) and an encouraging 2025 financial recovery with conservative leverage, but the moderate catalyst score (45) is significantly weighed down by ~$8M in insider selling that directly…
The first sentence of the analysis written for KN on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. – Insider: neutral. All sales (≈ $9.4M) were pre-planned Rule 10b5-1 trades, excluded from the score. No open-market buys or discretionary sales. – Initiés : neutre. Toutes les ventes (≈ $9.4M) sont sous plan 10b5-1 préétabli, exclues du score. Aucun achat ni vente discrétionnaire.
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 2.75 · operating margin 13%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 41.2% | 40.0% | 43.8% | 47.4% | 39.3% | |
| Ebit Margin | 12.4% | 9.9% | 9.8% | 19.1% | 13.7% | |
| Ebitda Margin | 18.5% | 16.7% | 15.5% | 30.4% | 20.9% | |
| Operating Profit Margin | 13.1% | 10.2% | 10.8% | 19.0% | 13.6% | |
| Pretax Profit Margin | 10.8% | 6.3% | 8.2% | 18.3% | 12.0% | |
| Continuous Operations Profit Margin | 8.6% | 4.2% | 14.4% | 13.9% | 17.3% | |
| Net Profit Margin | 7.5% | -43.3% | 15.8% | -89.8% | 17.3% | |
| Bottom Line Profit Margin | 7.5% | -43.3% | 15.8% | -89.8% | 17.3% | |
| Current Ratio | 2.752 | 1.829 | 2.605 | 3.657 | 2.288 | |
| Quick Ratio | 1.575 | 1.232 | 1.834 | 1.947 | 1.367 | |
| Solvency Ratio | 0.292 | -0.557 | 0.230 | -1.970 | 0.774 | |
| Cash Ratio | 0.512 | 0.658 | 0.530 | 0.486 | 0.415 | |
| Price To Earnings Ratio | 42.020 | -7.409 | 22.387 | -3.501 | 14.325 | |
| Price To Earnings Growth Ratio | -0.353 | 0.017 | -0.191 | 0.009 | 0.003 | |
| Forward Price To Earnings Growth Ratio | -0.353 | 0.017 | -0.191 | 0.009 | 0.003 | |
| Price To Earnings Diluted Ratio | 42.860 | -7.464 | 22.671 | -3.501 | 14.686 | |
| Price To Earnings Diluted Growth Ratio | -0.361 | 0.017 | -0.194 | 0.009 | 0.003 | |
| Price To Book Ratio | 2.370 | 2.344 | 1.574 | 1.516 | 1.477 | |
| Price To Sales Ratio | 3.100 | 3.201 | 3.564 | 3.145 | 2.483 | |
| Price To Free Cash Flow Ratio | 22.450 | 15.208 | 15.431 | 27.781 | 16.144 | |
| Price To Operating Cash Flow Ratio | 16.129 | 13.619 | 13.268 | 17.447 | 11.835 | |
| Debt To Assets Ratio | 0.143 | 0.190 | 0.196 | 0.054 | 0.059 | |
| Debt To Equity Ratio | 0.194 | 0.282 | 0.277 | 0.065 | 0.070 | |
| Debt To Capital Ratio | 0.162 | 0.220 | 0.217 | 0.061 | 0.066 | |
| Long Term Debt To Capital Ratio | 0.144 | 0.151 | 0.178 | 0.043 | 0.046 | |
| Financial Leverage Ratio | 1.355 | 1.479 | 1.415 | 1.192 | 1.186 | |
| Working Capital Turnover Ratio | 3.397 | 2.586 | 1.732 | 2.006 | 5.161 | |
| Operating Cash Flow Ratio | 1.076 | 0.658 | 0.745 | 0.871 | 1.096 | |
| Operating Cash Flow Sales Ratio | 0.192 | 0.235 | 0.269 | 0.180 | 0.210 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.718 | 0.895 | 0.860 | 0.628 | 0.733 | |
| Debt Service Coverage Ratio | 7.201 | 0.915 | 1.820 | 28.884 | 15.771 | |
| Interest Coverage Ratio | 8.355 | 2.821 | 6.676 | 21.116 | 8.208 | |
| Short Term Operating Cash Flow Coverage Ratio | 27.805 | 1.899 | 2.605 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.758 | 0.611 | 0.428 | 1.338 | 1.778 | |
| Capital Expenditure Coverage Ratio | 3.551 | 9.566 | 7.134 | 2.688 | 3.747 | |
| Dividend Paid And Capex Coverage Ratio | 2.977 | 9.566 | 7.134 | 2.688 | 3.747 | |
| Dividend Payout Ratio | 0.140 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 17.653 | 20.072 | 25.775 | 10.461 | 12.059 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 41.2% | ▲1.2% | ▼-1.1% |
| Ebit Margin | 12.4% | ▲2.5% | ▼-0.6% |
| Ebitda Margin | 18.5% | ▲1.8% | ▼-1.9% |
| Operating Profit Margin | 13.1% | ▲2.9% | ▼-0.2% |
| Pretax Profit Margin | 10.8% | ▲4.5% | ▼-0.3% |
| Continuous Operations Profit Margin | 8.6% | ▲4.3% | ▼-3.1% |
| Net Profit Margin | 7.4% | ▲50.7% | ▲25.9% |
| Bottom Line Profit Margin | 7.4% | ▲50.7% | ▲25.9% |
| Current Ratio | 2.752 | ▲0.923 | ▲0.126 |
| Quick Ratio | 1.575 | ▲0.343 | ▼-0.016 |
| Solvency Ratio | 0.292 | ▲0.850 | ▲0.539 |
| Cash Ratio | 0.512 | ▼-0.147 | ▼-0.009 |
| Price To Earnings Ratio | 42.020 | ▲49.428 | ▲28.455 |
| Price To Earnings Growth Ratio | -0.353 | ▼-0.370 | ▼-0.250 |
| Forward Price To Earnings Growth Ratio | -0.353 | ▼-0.370 | ▼-0.250 |
| Price To Earnings Diluted Ratio | 42.860 | ▲50.324 | ▲29.010 |
| Price To Earnings Diluted Growth Ratio | -0.361 | ▼-0.378 | ▼-0.256 |
| Price To Book Ratio | 2.370 | ▲0.026 | ▲0.514 |
| Price To Sales Ratio | 3.100 | ▼-0.101 | ▲0.001 |
| Price To Free Cash Flow Ratio | 22.451 | ▲7.242 | ▲3.047 |
| Price To Operating Cash Flow Ratio | 16.129 | ▲2.510 | ▲1.669 |
| Debt To Assets Ratio | 0.143 | ▼-0.048 | ▲0.014 |
| Debt To Equity Ratio | 0.194 | ▼-0.088 | ▲0.016 |
| Debt To Capital Ratio | 0.162 | ▼-0.058 | ▲0.017 |
| Long Term Debt To Capital Ratio | 0.144 | ▼-0.007 | ▲0.031 |
| Financial Leverage Ratio | 1.355 | ▼-0.124 | ▲0.029 |
| Working Capital Turnover Ratio | 3.397 | ▲0.810 | ▲0.420 |
| Operating Cash Flow Ratio | 1.077 | ▲0.418 | ▲0.187 |
| Operating Cash Flow Sales Ratio | 0.192 | ▼-0.043 | ▼-0.025 |
| Free Cash Flow Operating Cash Flow Ratio | 0.718 | ▼-0.177 | ▼-0.049 |
| Debt Service Coverage Ratio | 7.202 | ▲6.286 | ▼-3.717 |
| Interest Coverage Ratio | 8.355 | ▲5.534 | ▼-1.080 |
| Short Term Operating Cash Flow Coverage Ratio | 27.805 | ▲25.906 | ▲21.343 |
| Operating Cash Flow Coverage Ratio | 0.758 | ▲0.148 | ▼-0.224 |
| Capital Expenditure Coverage Ratio | 3.551 | ▼-6.015 | ▼-1.786 |
| Dividend Paid And Capex Coverage Ratio | 2.977 | ▼-6.590 | ▼-2.246 |
| Dividend Payout Ratio | 0.140 | ▲0.140 | ▲0.112 |
| Enterprise Value Multiple | 17.653 | ▼-2.419 | ▲0.449 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.84B | $1.77B | $1.63B | $1.51B | $2.16B | |
| Enterprise value | $1.93B | $1.85B | $1.83B | $1.52B | $2.19B | |
| EV / Sales | 3.26x | 3.35x | 4.00x | 3.18x | 2.52x | |
| EV / Op. cash flow | 16.97x | 14.26x | 14.89x | 17.64x | 12.02x | |
| EV / Free cash flow | 23.62x | 15.92x | 17.32x | 28.08x | 16.39x | |
| EV / EBITDA | 17.65x | 20.07x | 25.77x | 10.46x | 12.06x | |
| Net debt / EBITDA | 0.88x | 0.90x | 2.81x | 0.11x | 0.18x | |
| Current ratio | 2.75x | 1.83x | 2.60x | 3.66x | 2.29x | |
| Income quality | 2.58x | 5.56x | 1.87x | -0.20x | 1.21x | |
| Graham number | $10 | — | $14 | — | $24 | |
| Graham net-net | -$1 | -$1 | -$2 | $0 | -$0 | |
| Tax burden | 69.1% | -690.2% | 194.1% | -490.4% | 143.8% | |
| Interest burden | 87.3% | 63.3% | 83.4% | 95.7% | 87.9% | |
| Working capital | $185.5M | $163.8M | $264.2M | $263.3M | $214.1M | |
| Invested capital | $756.2M | $729.7M | $866.4M | $993.8M | $1.47B | |
| Return on assets | 4.2% | -21.4% | 4.9% | -36.3% | 8.7% | |
| Operating ROA | 7.2% | 4.4% | 3.7% | 6.2% | 7.0% | |
| Return on tangible assets | 6.9% | -34.7% | 7.1% | -68.5% | 21.7% | |
| Return on equity | 5.7% | -31.7% | 7.0% | -43.3% | 10.3% | |
| Return on invested capital | 6.5% | 3.8% | 3.7% | 6.3% | 7.5% | |
| Return on capital employed | 8.2% | 6.2% | 3.8% | 8.4% | 7.6% | |
| Earnings yield | 2.4% | -13.5% | 4.4% | -28.6% | 7.0% | |
| Free cash flow yield | 4.5% | 6.6% | 6.5% | 3.6% | 6.2% | |
| Capex / Op. cash flow | 28.2% | 10.5% | 14.0% | 37.2% | 26.7% | |
| Capex / Depreciation | 88.4% | 36.2% | 65.6% | 59.6% | 77.8% | |
| Capex / Sales | 5.4% | 2.5% | 3.8% | 6.7% | 5.6% | |
| SG&A / Sales | 24.1% | 23.0% | 26.1% | 24.4% | 15.0% | |
| R&D / Sales | 6.8% | 6.7% | 6.9% | 17.1% | 10.7% | |
| Stock comp / Sales | 4.8% | 0.0% | 0.0% | 6.0% | 0.0% | |
| Intangibles / Total assets | 39.1% | 38.2% | 30.5% | 47.0% | 60.0% | |
| Days sales outstanding | 63d | 69d | 72d | 103d | 62d | |
| Days payables outstanding | 45d | 64d | 51d | 60d | 63d | |
| Operating cycle | 194d | 199d | 253d | 348d | 168d | |
| Cash conversion cycle | 149d | 135d | 202d | 288d | 105d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-20 Knowles Corporation $KN Shares Sold by Bank of America Corp DE Bank of America Corp DE decreased its stake in shares of Knowles Corporation (NYSE: KN) by 9.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 755,323 shares of the communications equipment provider''s stock after selling 83,419 shares during
- 2026-08-14 Knowles (KN) Is Up 6.81% in One Week: What You Should Know Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let''s find out.
- 2026-08-12 Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device Elucent chooses Knowles for micro molding capabilities, design-for-manufacturability expertise, and vertically integrated assembly to accelerate production of their critical surgical guidance device. ITASCA, Ill.
- 2026-07-31 Conestoga SMid Cap Composite Q2 2026 Portfolio Review West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management''s guidance. We were attracted to Knowles'' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
- 2026-07-31 Bank of New York Mellon Corp Sells 32,082 Shares of Knowles Corporation $KN Bank of New York Mellon Corp reduced its stake in shares of Knowles Corporation (NYSE: KN) by 5.6% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned 543,697 shares of the communications equipment provider''s stock after selling 32,082 shares during the period. Bank of New
- 2026-07-29 All You Need to Know About Knowles (KN) Rating Upgrade to Strong Buy Knowles (KN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company''s earnings prospects. This might drive the stock higher in the near term.
- 2026-07-23 Knowles Q2 Earnings Call Highlights Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech & Specialty Audio.
- 2026-07-23 Knowles Corporation (KN) Q2 2026 Earnings Call Transcript Knowles Corporation (KN) Q2 2026 Earnings Call Transcript
- 2026-07-23 Knowles (KN) Beats Q2 Earnings and Revenue Estimates Knowles (KN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.24 per share a year ago.
- 2026-07-23 Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026 ITASCA, Ill.--(BUSINESS WIRE)--Knowles Corporation (NYSE: KN), a leading manufacturer of specialty electronic components, including high performance capacitors, radio frequency ("RF") filters, advanced medtech microphones, and balanced armature speakers, today announced results for the quarter ended June 30, 2026. “We delivered second quarter revenues exceeding the high end of our guided range. Non-GAAP diluted EPS was above the high end of our guided range and cash from operations was within t.